The latest news from ESMO 2024 focused on RCC including abstracts, features, and helpful conference information.
Protein glycosylation may predict response to NIVO+CABO vs SUN in aRCC, with glycopeptides and complement proteins linked to progression-free survival and outcomes.
The SUNNIFORECAST trial (LBA75), presented by Dr. Lothar Bergmann from Germany on Friday,...
Let us know if you attended ESMO 2024 in person.
Insights from the leaders in medical research, trending topics in clinical medicine, and perspectives from your colleagues.
Subscribe to our free Newsletters to receive weekly emails, and even get a laugh or two from our medical cartoons.
